B. Riley Wealth Advisors, Inc. - ORAMED PHARMACEUTICALS INC ownership

ORAMED PHARMACEUTICALS INC's ticker is ORMP and the CUSIP is 68403P203. A total of 46 filers reported holding ORAMED PHARMACEUTICALS INC in Q1 2021. The put-call ratio across all filers is 0.29 and the average weighting 0.1%.

Quarter-by-quarter ownership
B. Riley Wealth Advisors, Inc. ownership history of ORAMED PHARMACEUTICALS INC
ValueSharesWeighting
Q2 2021$280,000
+40.7%
20,883
+7.1%
0.01%
+28.6%
Q1 2021$199,000
+9850.0%
19,505
+3801.0%
0.01%
Q4 2014$2,000
-100.0%
5000.0%0.00%
-100.0%
Q2 2014$4,810,0005000.00%
Other shareholders
ORAMED PHARMACEUTICALS INC shareholders Q1 2021
NameSharesValueWeighting ↓
MORGAN JESS S & CO INC 315,301$1,444,0001.50%
Private Portfolio Partners LLC 54,010$247,3660.07%
Knoll Capital Management, LLC 20,000$92,0000.05%
Urban Wealth Management, LLC 2,858$13,0000.04%
OCCUDO QUANTITATIVE STRATEGIES LP 100,216$459,0000.04%
XTX Topco Ltd 18,174$83,0000.03%
Rossmore Private Capital 40,661$186,0000.03%
Ergoteles LLC 224,700$1,029,0000.03%
ETF MANAGERS GROUP, LLC 87,365$393,0000.01%
Belvedere Trading LLC 40,690$343,0000.01%
View complete list of ORAMED PHARMACEUTICALS INC shareholders